This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Reasons to Hold on to Interpublic Group (IPG) Stock For Now
by Zacks Equity Research
Interpublic's (IPG) increasingly diverse workforce enables organic growth and strengthening of foothold in international markets.
FTI Consulting (FCN) Hires Senior MD for Transactions Practice
by Zacks Equity Research
FTI Consulting (FCN) welcomes Cedric Burgher to the position of senior managing director in its Transactions practice within the Corporate Finance & Restructuring segment.
Reasons to Retain Rollins (ROL) Stock in Your Portfolio
by Zacks Equity Research
Rollins (ROL) is currently benefiting from its balanced approach to organic and inorganic growth.
Charles River (CRAI) Announces Name of New VP in Oakland
by Zacks Equity Research
Charles River (CRAI) welcomes Elizabeth Bailey to the position of vice president of its Antitrust & Competition Economics Practice in Oakland.
Cross Country Healthcare (CCRN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Cross Country Healthcare (CCRN) closed at $23.55 in the latest trading session, marking a -1.63% move from the prior day.
Reasons to Add Republic Services (RSG) Stock to Your Portfolio
by Zacks Equity Research
Republic Services (RSG) continues to focus on its strategic priority of increasing customers' loyalty and their willingness to pay for higher-value services.
IQVIA Holdings (IQV) Stock Up 34.4% In a Year: Here's Why
by Zacks Equity Research
Consecutive better-than-expected top- and bottom-line performances and shareholder-friendly moves have been aiding IQVIA Holdings (IQV) stock.
Five Reasons to Add Genpact (G) Stock in Your Portfolio Now
by Zacks Equity Research
Solid cash balance, investor-friendly steps and artificial intelligence boost Genpact (G).
5 Reasons Why You Should Invest in S&P Global (SPGI) Stock
by Zacks Equity Research
Acquisitions enable S&P Global (SPGI) to innovate, increase differentiated content and develop new products.
Reasons to Hold on to ICF International (ICFI) Stock For Now
by Zacks Equity Research
ICF (ICFI) continues to witness revenue growth from government and commercial energy clients.
5 DuPont-Tested Quality Stocks to Beat Market Woes
by Sanghamitra Saha
Bet on five top-ranked stocks with higher ROE derived the DuPont way. These stocks are SAFM, BLDR, XPEL, EXPD and CCRN.
Charles River (CRAI) Hires New Forensic Services Practice VP
by Zacks Equity Research
Charles River (CRAI) welcomes Peggy Daley to the position of vice president its Energy Practice.
FTI Consulting (FCN) Announces Appointments of Senior Officials
by Zacks Equity Research
FTI Consulting (FCN) welcomes Guy Davis and JP Eldred to the positions of senior managing director and managing director, respectively, within its Corporate Finance & Restructuring segment.
S&P Global (SPGI) Set to Gain From Climate Service Buyout
by Zacks Equity Research
The deal is expected to enhance S&P Global's (SPGI) portfolio of essential ESG data, scores, benchmarks and insights.
Reasons Add LiveRamp Holdings (RAMP) Stock to Your Portfolio
by Zacks Equity Research
The acquisition of DataFleets significantly expands LiveRamp's (RAMP) privacy protection capabilities.
Genpact (G) Buys Up Hoodoo Digital to Boost Experience Business
by Zacks Equity Research
Addition of Hoodoo Digital boosts Genpact's (G) capabilities in supporting client's content, commerce and marketing operation management processes.
Here's Why Investors Should Buy Accenture (ACN) Stock Now
by Zacks Equity Research
Solid cash balance and strategic buyouts are boosting Accenture's (ACN) shares.
ICF (ICFI) Completes Creative Systems and Consulting Buyout
by Zacks Equity Research
The acquisition is expected to complement ICF's (ICFI) ServiceNow and Appian capabilities.
Reasons to Retain Trane Technologies (TT) Stock For Now
by Zacks Equity Research
Trane Technologies (TT) focuses on improving its business operating system and innovation through transformation initiatives and investments.
Here's Why You Should Retain Broadridge (BR) in Your Portfolio
by Zacks Equity Research
Broadridge (BR) is backed by higher recurring fee revenues and shareholder-friendly measures. However, high debt is a concern.
Paychex (PAYX) Gains on Cash Strength & Investor-Friendly Steps
by Zacks Equity Research
Paychex (PAYX) puts consistent efforts to reward shareholders through dividend payouts and share repurchases.
Cross Country Healthcare (CCRN) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Cross Country Healthcare (CCRN) closed at $27.80, marking a +0.14% move from the previous day.
5 Reasons Why You Should Invest in Charles River (CRAI) Stock
by Zacks Equity Research
Charles River (CRAI) rides on its strong global presence, business diversification and an excellent professional team.
Reasons to Add Hudson Global (HSON) Stock to Your Portfolio
by Zacks Equity Research
The 2020 acquisition of Coit has significantly expanded HudonGlobal's (HSON) foothold in the technology space.
Here's Why You Should Add Booz Allen (BAH) in Your Portfolio
by Zacks Equity Research
Artificial intelligence, advanced engineering, directed energy and modern digital platforms boost Booz Allen (BAH) stock.